High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid Salmonella clinical isolates in Asia

Hao Yuan Lee, Lin Hui Su, Ming Han Tsai, Shin Woo Kim, Hyun Ha Chang, Sook In Jung, Kyung Hwa Park, Jennifer Perera, Celia Carlos, Hock Tan Ban, Gamini Kumarasinghe, Thomas So, Anan Chongthaleong, Po Ren Hsueh, Jien Wei Liu, Jae Hoon Song, Cheng Hsun Chiu

Research output: Contribution to journalArticlepeer-review

108 Scopus citations

Abstract

This multinational study from Asia revealed that reduced susceptibility to ciprofloxacin (MIC, 0.125 to 1 μg/ml) in nontyphoid Salmonella isolates was common in Taiwan (48.1%) and Thailand (46.2%) and in S. enterica serotype Choleraesuis (68.8%) and S. Virchow (75.0%) from all countries. Reduced susceptibility to ceftriaxone (MIC, 2 to 8 μg/ml) remained uncommon in Asia, except in Taiwan (38.0%) or in S. Typhimurium (25.0%) from all countries.

Original languageEnglish
Pages (from-to)2696-2699
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Volume53
Issue number6
DOIs
StatePublished - Jun 2009

Fingerprint

Dive into the research topics of 'High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid Salmonella clinical isolates in Asia'. Together they form a unique fingerprint.

Cite this